anmelden
Stoxx Europe 50
5.441,59
PKT
-53,26
PKT
-0,97
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.11.23 | ING Group Buy | Jefferies & Company Inc. | |
| 02.11.23 | ING Group Buy | UBS AG | |
| 02.11.23 | ING Group Buy | Deutsche Bank AG | |
| 02.11.23 | ING Group Sector Perform | RBC Capital Markets | |
| 02.11.23 | Rheinmetall Overweight | Barclays Capital | |
| 02.11.23 | Schneider Electric Overweight | JP Morgan Chase & Co. | |
| 02.11.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 02.11.23 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.11.23 | BBVA Buy | UBS AG | |
| 01.11.23 | GSK Sell | UBS AG | |
| 01.11.23 | HSBC Neutral | UBS AG | |
| 01.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 01.11.23 | Roche Sell | Deutsche Bank AG | |
| 01.11.23 | BBVA Buy | Deutsche Bank AG | |
| 01.11.23 | AB InBev SA-NV (Anheuser-Busch InBev) Buy | Deutsche Bank AG | |
| 01.11.23 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.11.23 | BP Buy | Goldman Sachs Group Inc. | |
| 01.11.23 | UniCredit Buy | Jefferies & Company Inc. | |
| 01.11.23 | Münchener Rückversicherungs-Gesellschaft Overweight | JP Morgan Chase & Co. | |
| 01.11.23 | AB InBev SA-NV (Anheuser-Busch InBev) Overweight | JP Morgan Chase & Co. | |
| 01.11.23 | BP Underweight | JP Morgan Chase & Co. | |
| 31.10.23 | BBVA Neutral | JP Morgan Chase & Co. | |
| 31.10.23 | HSBC Outperform | RBC Capital Markets | |
| 31.10.23 | AB InBev SA-NV (Anheuser-Busch InBev) Hold | Jefferies & Company Inc. | |
| 31.10.23 | HSBC Overweight | Barclays Capital | |
| 31.10.23 | BP Neutral | JP Morgan Chase & Co. | |
| 31.10.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.10.23 | Rolls-Royce Overweight | Barclays Capital | |
| 31.10.23 | BP Hold | Jefferies & Company Inc. | |
| 31.10.23 | BP Buy | Goldman Sachs Group Inc. | |
| 31.10.23 | AB InBev SA-NV (Anheuser-Busch InBev) Neutral | Goldman Sachs Group Inc. | |
| 31.10.23 | BBVA Neutral | Goldman Sachs Group Inc. | |
| 31.10.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.10.23 | AB InBev SA-NV (Anheuser-Busch InBev) Overweight | JP Morgan Chase & Co. | |
| 31.10.23 | AB InBev SA-NV (Anheuser-Busch InBev) Outperform | Bernstein Research | |
| 31.10.23 | AB InBev SA-NV (Anheuser-Busch InBev) Hold | Jefferies & Company Inc. | |
| 31.10.23 | BBVA Buy | UBS AG | |
| 31.10.23 | AB InBev SA-NV (Anheuser-Busch InBev) Sell | UBS AG | |
| 31.10.23 | BP Outperform | RBC Capital Markets | |
| 31.10.23 | BP Buy | UBS AG |
